USPTO trademark

MAPELDA

Under examinationUSPTOWord markClass 5

"MAPELDA" is a word mark owned by AstraZeneca AB, filed at the USPTO on February 12, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View AstraZeneca AB portfolioGet this data via the API
Official USPTO record
MAPELDA trademark as filed
As filed with the USPTO
Status
Under examination
Since June 5, 2026
Filed
February 12, 2026
Registered
Not yet
Priority date
September 10, 2025
Claimed from European Union
Application no.
99649268
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns MAPELDA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca AB

Sodertalje, Sweden

6,107 trademarks in the portfolioView company

Representative

Leonid Rakitin

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services MAPELDA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Notification of letter of suspension e-mailed
  5. Letter of suspension e-mailed
  6. Suspension letter written
  7. Assigned to examiner
  8. New application office supplied data entered
  9. Application filing receipt mailed
  10. New application entered
FAQ

About MAPELDA

Who owns the trademark "MAPELDA"?

The USPTO trademark "MAPELDA" (application 99649268) is owned by AstraZeneca AB.

What is the status of "MAPELDA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MAPELDA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ba4-9745-77df-aaac-c6ce1cf6c136
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ba4-9745-77df-aaac-c6ce1cf6c136",
  "object": "trademark",
  "mark_text": "MAPELDA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99649268",
  "filing_date": "2026-02-12",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca AB",
      "entity_id": "ent_019eb700-571d-718e-bf3d-80fe37712629"
    }
  ]
}